Postoperative functional status, rather than extent of resection, predicts survival in butterfly glioblastoma: A single-center retrospective study
This single-center retrospective study of 23 butterfly glioblastoma patients concludes that postoperative functional status, rather than the extent of surgical resection, is the primary predictor of survival, suggesting that aggressive resection should only be pursued when it can be achieved without causing functional deterioration.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The brain is a complex organ, but some tumors present a unique challenge that defies standard surgical rules. One such condition is known as butterfly glioblastoma. This is a highly aggressive form of brain cancer that does not stay confined to one side of the brain. Instead, it spreads across the midline, crossing a thick bundle of nerve fibers called the corpus callosum that connects the left and right hemispheres. Because the tumor bridges these two halves, it resembles the wings of a butterfly when viewed on a scan. Historically, surgeons have been hesitant to operate on these tumors. The fear was that removing such a widespread mass would cause severe damage to the brain's communication lines, leaving the patient worse off than before. For decades, the prevailing question in the medical community was whether the potential benefit of removing the tumor outweighed the high risk of neurological injury.
A team of researchers at Kyoto University Graduate School of Medicine set out to answer this question by looking back at the treatment records of twenty-three patients who had undergone surgery for this specific type of cancer between 2007 and 2025. Their goal was to determine what actually predicts how long a patient survives: is it the amount of tumor removed, or is it the patient's ability to function well after the operation? The study focused on two main outcomes. First, they looked at overall survival, which is simply the time from the surgery until the patient passes away from any cause. Second, they examined progression-free survival, which measures the time until the cancer begins to grow again or spread. Crucially, they also tracked the patients' functional status using a standard scale called the Karnofsky Performance Status. This scale measures how well a person can care for themselves and perform daily activities, with higher scores indicating better function. The researchers wanted to see if a patient's ability to recover their independence after surgery mattered more than the sheer volume of cancer tissue the surgeon managed to cut out.
The results of this study suggest a shift in how surgeons should approach these difficult cases. The team found that the amount of tumor removed was not the primary driver of how long patients lived. While removing a large portion of the tumor might help control the disease in the very early stages, it did not significantly extend the total lifespan of the patients in this group. Instead, the most powerful predictor of survival was how well the patient was functioning two weeks after the surgery. Patients who maintained a higher level of independence and mobility two weeks post-operation lived longer. Conversely, if a patient's condition worsened significantly after the surgery and they remained impaired two weeks later, their survival time was shorter. This finding highlights that preserving the patient's quality of life and neurological function is more critical than attempting to remove every last bit of the tumor if doing so risks causing permanent damage.
The researchers also investigated the specific risks associated with the surgery. They found that complications such as bleeding, strokes, or specific neurological syndromes were the main reasons patients experienced a lasting decline in their functional status. Interestingly, the act of removing the tumor-infiltrated part of the connecting nerve bundle itself did not automatically lead to long-term disability. In many cases, the temporary weakness or confusion seen immediately after surgery improved within two weeks, provided no major complications occurred. This suggests that surgeons can be more aggressive in removing the tumor tissue that crosses the midline, as long as they can do so without injuring the surrounding blood vessels or healthy brain tissue. The study indicates that if a surgeon can safely remove at least eighty-five percent of the tumor, it may help delay the return of the cancer, but this must be balanced against the risk of causing a permanent decline in the patient's ability to function.
Ultimately, the study concludes that the decision to operate should be guided by safety and the preservation of function rather than the pursuit of a perfect removal. The data showed no significant difference in survival between patients who had a full surgical removal and those who only had a small tissue sample taken for diagnosis, provided that the patients in the surgery group did not suffer major complications. This implies that the benefit of surgery comes from the ability to maintain the patient's health and allow them to receive follow-up treatments like radiation and chemotherapy, rather than from the removal of the tumor mass itself. For patients with this rare and challenging condition, the path forward appears to be a careful, individualized approach where the surgeon prioritizes keeping the patient's brain working well, accepting that a complete removal is not always necessary or safe. The findings suggest that in the battle against butterfly glioblastoma, protecting the patient's future function is the most effective strategy for extending their life.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.